Development of a novel lncRNA-derived immune gene score using machine learning-based ensembles for predicting the survival of HCC.
Autor: | Cai Q; Department of Infectious Diseases and Liver Diseases, Ningbo Medical Center Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, 1111 Jiangnan Rd., Ningbo, 315100, China. quncai@zju.edu.cn., Li G; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150036, Heilongjiang, China., Zhu M; Department of Infectious Diseases and Liver Diseases, Ningbo Medical Center Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, 1111 Jiangnan Rd., Ningbo, 315100, China., Zhuo T; Department of Infectious Diseases and Liver Diseases, Ningbo Medical Center Lihuili Hospital, Affiliated Lihuili Hospital of Ningbo University, 1111 Jiangnan Rd., Ningbo, 315100, China., Xiao J; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150036, Heilongjiang, China. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Feb 09; Vol. 150 (2), pp. 86. Date of Electronic Publication: 2024 Feb 09. |
DOI: | 10.1007/s00432-024-05608-6 |
Abstrakt: | Background: Long noncoding RNAs (lncRNAs) are implicated in the tumor immunology of hepatocellular carcinoma (HCC). Methods: HCC mRNA and lncRNA expression profiles were used to extract immune-related genes with the ImmPort database, and immune-related lncRNAs with the ImmLnc algorithm. The MOVICS package was used to cluster immune-related mRNA, immune-related lncRNA, gene mutation and methylation data on HCC from the TCGA. GEO and ICGC datasets were used to validate the model. Data from single-cell sequencing was used to determine the expression of genes from the model in various immune cell types. Results: With this model, the area under the curve (AUC) for 1-, 3- and 5-year survival of HCC patients was 0.862, 0.869 and 0.912, respectively. Single-cell sequencing showed EREG was significantly expressed in a variety of immune cell types. Knockdown of the EREG target gene resulted in significant anti-apoptosis, pro-proliferation and pro-migration effects in HepG2 and HUH7 cells. Moreover, serum and liver tissue EREG levels in HCC patients were significantly higher than those of healthy control patients. Conclusion: We built a prognostic model with good accuracy for predicting HCC patient survival. EREG is a potential immunotherapeutic target and a promising prognostic biomarker. (© 2024. The Author(s).) |
Databáze: | MEDLINE |
Externí odkaz: |